Search Results 11-20 of 25540 for treatment resistant depression
Long-term Outcomes of a Clinical Ketamine Service for Treatment-resistant Depression · Overview · Participation eligibility · Participating Mayo Clinic locations.
Vilazodone (Viibryd); Vortioxetine (Trintellix). A new antidepressant called esketamine (Spravato) is FDA approved for treatment-resistant depression.
Areas of research include: Developing effective treatments for treatment-resistant depression; Genetic and environmental factors in depression; How genomic ...
Esketamine, a version of the drug ketamine, has been approved for treatment-resistant depression. "Ketamine is a mixture of two enantiomers of a drug, meaning ...
When used for depression, OCD and to stop smoking, this treatment involves delivering repeated magnetic pulses, so it's called repetitive TMS or rTMS . How it ...
Adjunctive Lithium for Patients Receiving Clinical Intravenous Ketamine for Treatment Resistant Depression (TRD) Rochester, MN. The purpose of this study is ...
Depression may require long-term treatment. But don't get discouraged. Most people with depression feel better with medication, psychotherapy or both.
... treatment-resistant depression. The department offers: Experience. Mayo Clinic experts have performed rTMS treatments for depression since 2002 as a part of ...
This herbal supplement is not approved by the Food and Drug Administration (FDA) to treat depression in the U.S., but it's available. Although it may be helpful ...
The Food and Drug Administration (FDA) approved these tricyclic antidepressants to treat depression ... Treatment-resistant depression · Unexplained weight loss ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can go twice as far to fight cancer.